Hi Rorbag - cap raise assessment was back of the envelope... Costs approx $8M pa. AAR currently $1.8M and predicted to go to a maximum of $4.2M by "early 2023". So approx a $4M shortfall with $6.9M in the bank. Need to double the assumed AAR revenue of $4.2M to cover costs to be sustainable. So they have 5 to 6 quarters to do this to avoid another cap raise. Not an insignificant task - but lots of irons in the fire
Risks are:
- Cost base increase due to international expansion, infant app launch, FDA approval?
- Slower rate of implementation of current licences
- Poor conversion of the $2M AAR govt funded beds to commercial contracts. Hard to believe there is still 12,870 beds ($0.5M) that were govt funded but not yet implemented
I'm slightly more optimistic than Fattchoi & Screenlover and reckon PCK will be revenue neutral in 2024 rather than 2025 - but have been wrong before!!! Also believe/hopeful that there should be healthy SP growth over this time
Saw Portugal but not Brazil or Canada - but use the free version of APPlyzer
- Forums
- ASX - By Stock
- PCK
- PainChek General Discussion
PainChek General Discussion, page-20285
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.004(11.1%) |
Mkt cap ! $65.43M |
Open | High | Low | Value | Volume |
3.6¢ | 4.0¢ | 3.5¢ | $58.14K | 1.592M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 606713 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 1458683 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.039 |
1 | 200000 | 0.038 |
1 | 50000 | 0.036 |
2 | 262933 | 0.035 |
1 | 24813 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 1458683 | 2 |
0.041 | 565454 | 2 |
0.042 | 212300 | 2 |
0.043 | 181299 | 2 |
0.044 | 475304 | 4 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |